E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/9/2010 in the Prospect News High Yield Daily.

New Issue: MedAssets prices $325 million eight-year notes at par to yield 8%

By Paul A. Harris

St. Louis, Nov. 9 - MedAssets, Inc. priced a downsized $325 million issue of eight-year senior notes (B3/B-/) at par to yield 8% on Tuesday, according to a market source.

The yield printed at the tight end of the 8% to 8¼% price talk.

J.P. Morgan Securities LLC and Barclays Capital Inc. were the bookrunners for the issue, which was downsized from $360 million, with $35 million shifted to the bank loan.

Proceeds will be used to pay a portion of the $850 million acquisition of the Broadlane Group.

MedAssets is an Atlanta-based provider of supply chain consulting and revenue cycle management services for health systems, hospitals and health care providers.

Issuer:MedAssets, Inc.
Amount:$325 million, decreased from $360 million
Maturity:Nov. 15, 2018
Securities:Senior notes
Bookrunners:J.P. Morgan Securities LLC, Barclays Capital Inc.
Coupon:8%
Price:Par
Yield:8%
Spread:597 bps
Call protection:Four years
Trade date:Nov. 9
Settlement date:Nov. 16
Ratings:Moody's: B3
Standard & Poor's: B-
Distribution:Rule 144A and Regulation S
Price talk:8% to 8¼%
Marketing:Roadshow

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.